Dutch chemical company Avantium officially announced on September 8, 2026 that it has completed startup of all major process units and commissioning of the purification unit at its FDCA (2,5-furandicarboxylic acid) flagship plant in Delfzijl. FDCA is used as feedstock for the bio-based plastic PEF (polyethylene furanoate) and is reported to be the world’s first commercial-scale production facility of its kind.
The plant is the world’s first commercial-scale facility producing FDCA from plant-based feedstock, and following completion of purification unit commissioning, it is reported to be transitioning to initial batch production of FDCA. FDCA is regarded as a key fine chemical feedstock for the bio-based plastic PEF, which can replace conventional petroleum-based PET (polyethylene terephthalate). The specific process licensor or catalyst supplier has not been separately disclosed.
The announcement was made on September 8, 2026, with startup of all major process units and commissioning of the purification unit completed. Commercial sales, based on already-signed offtake agreements, are targeted to begin by the end of 2026, contingent on successful operation and quality verification.
Avantium is reported to have pursued the FDCA flagship plant with the goal of commercializing bio-based materials that can replace petroleum-based plastics. As the world’s first commercial-scale facility of its kind, this commissioning completion is seen as a milestone marking the bioplastics industry’s entry into the commercial production stage.
This commissioning completion is seen as illustrating that bio-based plastic materials are moving beyond the laboratory and pilot stages into commercial production. PEF is known to offer superior oxygen and carbon dioxide barrier properties compared to conventional PET, drawing attention in the food and beverage packaging market, and a successful start of commercial FDCA production could mark an important turning point for expanding the PEF-based packaging market. As the world’s first commercial-scale facility, how initial operations stabilize and quality verification results turn out are seen as key variables that will determine whether Avantium can expand its licensing business going forward. It is also worth noting that a European company is leading commercialization of new materials in the fine chemicals and specialty materials sector, which aligns with the EU’s broader emphasis on circular economy and bio-based materials policy. Whether customers with existing offtake agreements actually begin purchasing is also likely to draw market attention.
Whether quality verification succeeds during initial batch production, and whether commercial sales actually begin as targeted by year-end, are the most important points to watch. Which companies have signed offtake agreements, and when actual volume off-take will begin, is also of interest. Whether Avantium pursues further production capacity expansion or technology licensing following successful commercialization also needs to be confirmed. How the PEF-based packaging market expands following this commercialization also remains to be seen.